Form 8-K - Current report:
SEC Accession No. 0001789769-25-000050
Filing Date
2025-05-13
Accepted
2025-05-13 07:05:44
Documents
15
Period of Report
2025-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20250513.htm   iXBRL 8-K 33532
2 EX-99.1 q1-25er.htm EX-99.1 59405
6 GRAPHIC image.jpg GRAPHIC 3565
  Complete submission text file 0001789769-25-000050.txt   232209

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20250513.xsd EX-101.SCH 1773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20250513_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20250513_pre.xml EX-101.PRE 13038
17 EXTRACTED XBRL INSTANCE DOCUMENT til-20250513_htm.xml XML 2998
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 25937097
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)